Johnson & Johnson Is Still a Top Dividend Stock
Over the years, blue-chip stocks have delivered a tremendous
amount of value to income investors. But because many large-cap companies have
also become household names, their share prices have gotten expensive.
Therefore, when something as solid as Johnson & Johnson (NYSE:JNJ) stock is
having a pullback, it deserves the attention of income investors.
Johnson & Johnson is a healthcare giant. Starting out
making ready-to-use surgical dressings in the 1880s, Johnson & Johnson has
become a multinational medical, pharmaceutical, and consumer goods
manufacturer. It’s one of the largest companies in the world, commanding more
than $340.0 billion of market cap.
Mega-cap companies with established market positions are not
known for making big moves in their share prices. But in the recent correction
of the U.S. stock market, even large-cap stocks took a huge hit. In particular,
shares of Johnson & Johnson have plunged by more than 13% since their
January high, an unusually large drop for the healthcare behemoth.
Still, for investors who are looking to add a blue-chip
company to their income portfolios, JNJ stock’s latest pullback could represent
an opportunity.
Let me explain…
Comments
Post a Comment